4//SEC Filing
Regnante Keith 4
Accession 0001209191-21-003274
CIK 0001664710other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:25 PM ET
Size
5.6 KB
Accession
0001209191-21-003274
Insider Transaction Report
Form 4
Regnante Keith
CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2021-01-10+49,150→ 49,150 totalExercise: $70.93Exp: 2031-01-09→ Common Stock (49,150 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on January 7, 2022, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001682068
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 5:25 PM ET
- Size
- 5.6 KB